Product NDC: | 0228-3503 |
Proprietary Name: | Morphine sulfate |
Non Proprietary Name: | Morphine sulfate |
Active Ingredient(s): | 30 mg/1 & nbsp; Morphine sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0228-3503 |
Labeler Name: | Actavis Elizabeth LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020616 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20111111 |
Package NDC: | 0228-3503-11 |
Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3503-11) |
NDC Code | 0228-3503-11 |
Proprietary Name | Morphine sulfate |
Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3503-11) |
Product NDC | 0228-3503 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Morphine sulfate |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20111111 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Actavis Elizabeth LLC |
Substance Name | MORPHINE SULFATE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |